AstraZeneca to Talk With Shareholders After Low Support for AGM Resolutions
By Adria Calatayud
AstraZeneca PLC said Tuesday that it will engage with
shareholders after some resolutions put to vote at its annual
general meeting received significant minority opposition.
The British pharmaceutical giant said its directors'
remuneration policy was supported by 60.19% of votes cast at the
meeting, while a proposal to amend the rules of its 2020
performance-share plan was backed by 61.72% of votes cast. A
resolution to re-elect Sheri McCoy as a director received the
support of 74.03% of the votes cast.
AstraZeneca said its board noted the lower of support received
for these resolutions. The board has engaged with some shareholders
to understand the reasoning behind their decision not to support
the resolutions and will continue to do so during 2021, the company
Write to Adria Calatayud at email@example.com
(END) Dow Jones Newswires
May 11, 2021 09:27 ET (13:27 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.